Meiji Seika Pharma Co., Ltd.

Meiji Seika Pharma Co., Ltd. (Japan) holds 3 active US FDA Type II Drug Master Files and 4 inactive, has DMF or CEP filings on record for 4 active ingredients and is linked to 2 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Meiji Seika Pharma Co., Ltd.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/meiji-seika-pharma-co-ltd

Overview

Meiji Seika Pharma Co., Ltd., is a leading pharmaceutical company based in Japan, specializing in the development and marketing of pharmaceutical drugs. It is a subsidiary of Meiji Holdings Co., Ltd., focusing on providing innovative solutions in infectious disease treatment and central nervous system therapies.

Core services & business areas

Drug DevelopmentManufacturingResearch and DevelopmentRegulatory AffairsQuality Assurance

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Meiji Seika Pharma Co., Ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Meiji Seika Pharma Co., Ltd. holds 3 active (7 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • ME3183Active2018-11-21
  • DAUNORUBICIN HYDROCHLORIDE (DRUG SUBSTANCE)Active1998-09-01
  • DOXORUBICIN HYDROCHLORIDE DRUG SUBSTANCEActive1998-04-30
  • ME1111 DRUG SUBSTANCEInactive2012-11-12
  • ARBEKACIN FREE BASE DRUG SUBSTANCE (ME1100)Inactive2012-06-08
  • ARBEKACIN SULFATE DRUG SUBSTANCEInactive2011-09-30
  • CEFDITOREN PIVOXIL DRUG SUBSTANCEInactive2004-06-22

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to Meiji Seika Pharma Co., Ltd., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Meiji Seika Pharma Co., Ltd. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Meiji Seika Pharma Co., Ltd.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.